RNCOS Releases a New Report- Japanese Generic Market Forecast to 2013By: Shushmul Maheshwari
|
RNCOS Releases a New Report- Japanese Generic Market Forecast to 2013
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
According to “Japanese Generic Market Forecast to 2013”, a new research report by RNCOS, Japan promises to be one of the most lucrative generic markets in the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in revenue.
The Japanese market is characterized by a strong support by the government, which in a desperate bid to limit its healthcare costs, is introducing a number of generic-friendly policies. Other factors such as a large number of patent expiries and the largely un-penetrated nature of the market are also contributing towards the market growth.
The generic market is presently dominated by domestic manufacturers, with the top six manufacturers accounting for 56% of the total market in 2007. But opening up of the market and introduction of a number of generic-friendly reforms is attracting a number of foreign players in the market.
Despite such a big opportunity for future, the market also has a number challenges to deal with. Generic drugs are still regarded as cheap, low quality alternatives of branded drugs. Thus, both physicians and patients are skeptic regarding their safety and efficacy. A number of awareness and educational programs, however, are expected to increase their awareness in future.
Despite these challenges, our forecast models suggest that the generic drugs market will grow at a CAGR of around 8.8% between 2009 and 2013.
The report gives an extensive and objective analysis on the generic market in Japan. It investigates both the past and present trends in the generic market, but its focus is on the future trends shaping the industry. The report also investigates the performance of various players in the Japanese pharmaceutical and generic markets, and analyzes the competitive landscape in these markets. Based on various present and future indicators, the future scenario of the market has also been analyzed.
Key questions answered in the report
- What is the size and penetration level of the Japanese generic market?
- How is the Japanese generic market different from other developed markets?
- What are the key drivers and challenges for the generic market?
- What is the role of government in the market?
- What is the viewpoint of patients and physicians on generic drugs?
- What is the future outlook of the drug market?
- Who are the key players operating in the Japanese generic market?
Key players operating in Japanese generic market
This report features the key players currently operating in the Japanese pharmaceutical and generic markets. This section describes market shares and growth of key pharmaceutical and generic players in Japan. Profiles of the top six generic manufacturers have been provided in the report.
For more information visit: http://www.rncos.com/Report/IM170.htm
Current Industry News: http://www.rncos.com/Blog/http://www.rncos.com |
|
| Keywords |
Japanese Generic Market Forecast to 2013, Japanese Generic Industry, Generic Market of Japan, Market Research Report |
| Category |
Health and Fitness |
| Submission Date |
Apr 15, 2009 |
| Article Contact Name |
Shushmul Maheshwari || send email to Shushmul Maheshwari
|
|
Other links at Health and Fitness |
| 1. |
BRIC & Eastern European Nations Lead Global Pharma Sector amidst Recession
|
|
|
With increasing lifestyle-related ailments, improvement in life expectancy rate and soaring healthcare spending worldwide, the global pharmaceutical market is projected to generate revenue of nearly US$ 1043.4 Billion by 2012, said RNCOS new research report “Global Pharmaceutical Market Forecast to 2012”.
According to a Senior Research Analyst at RNCOS, the global pharmaceutical market will not see much impact of ongoing global economic meltdown as it is considered the recession proof industry. However, the sales of some chronic and OTC drugs have slightly plunged as people cut down spending on medicines following the impact of economic meltdown on their pocket.
Under the current scenario, the growth of pharmaceutical market in developed countries will slowdown, but it will sustain in emerging markets. The US (world’s largest pharmaceutical market) posted the slowest growth in several decades, whereas the BRIC countries (Brazil, Russia, India and China) along with some eastern European countries registered sustained double-digit growth. Thus, pharmaceutical manufacturers are focusing on these countries to keep rolling their businesses.
The global pharmaceutical market is gaining growth momentum all around the world, creating immense opportunities for various players to expand their business operations. It will open new growth avenues in different areas such as clinical trial market, RFID market, pharmaceutical packaging market, medical devices, logistics devices and health insurance.
“Global Pharmaceutical Market Forecast to 2012” provides comprehensive and qualitative analysis on major pharmaceutical markets all around the globe, with focus on both current and past trends. The report enables pharmaceutical manufacturers/investors/consultants studying the global pharmaceutical market to identify and analyze growth opportunities that will suit their business requirements and profiles. It also gives forecasts on various segments of pharmaceutical market along with healthcare statistics by countries.
The extent of information covered in the report will help clients to comprehend the industry dynamics and the corresponding factors responsible for transformation of the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM149.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
|
| 2. |
What is chronic back pain?
|
|
|
What is chronic back pain?
Chronic back pain is defined as pain in the back region that lasts from more than three months. It is also the most common ailment among inhabitants of the UK, as some 60-80 percent of residents say that they experience significant chronic back pain.
As chronic back pain can be indicative of extremely serious medical conditions – including cancer, it is best to investigate the cause right away.
Acute or chronic back pain?
Chronic back pain is often attributed to degenerative disorders or traumatic conditions of the spine. Additionally, it is also associated with various ailments, including fibrositis, inflammatory spondyloarthropathy, and metabolic bone conditions.
It can also strike anyone at any age, race or social station; however, the affliction appears to most often strike people between the ages of 45-59.
There are three levels of back pain, namely chronic, sub acute and acute back pain. Acute back pain is when the pain only last for about six weeks, sub acute back pain lasts for about 6-12 weeks and chronic back pain lasts for 12 weeks and beyond.
What causes chronic back pain?
While there is no one underlying cause for chronic back pain, research indicates that there are various risk factors for the development of chronic back pain. Some of these risk factors include cigarette smoking, twisting in awkward positions due to a repetitive job or sport, forwards bending, constant, strenuous physical activity, morbid obesity and exposure to intense vibrations causes by motorized vehicles or industrial machines.
Another cause is chronic nerve root back pain, which occurs in less that 5% of all cases. This type of chronic back pain is generally caused by a slipped disc, which compressed the nerve as it leaves the spinal cord.
More serious chronic back pain
In an even smaller amount of cases, chronic back pain can be caused by severe, in some cases, potentially deadly conditions, like tuberculosis or cancer. An abnormality of the spine or an infection can also be a serious underlying cause of chronic back pain; this is why it is always best to visit a doctor if the pain persists.
Will Painwave X4000 help with chronic back pain?
It surely can! Just what is Painwave X4000? It is a space age, non-invasive drug free pain management technology that utilizes the body's own bioelectromagnetic ecosystem to block pain receptors. By simply moving the unit in a circular motion over the affected area, the Painwave X4000 will eliminate pain and in time possibly eradicate it for good. The Painwave X4000 can also help improve blood circulation as well as stimulate lymphatic movements and cell activity. In the end, the Painwave X4000 is a safe and effective way to get rid of chronic, debilitating pain.
Note: This article is an informative guide that should only be used for gathering information regarding arthritis, not to perform a self-diagnosis. Only a medical practitioner can definitively ascertain if you have arthritis or not. If you have concerns in this regard, please contact your personal physician right away.
|
| 3. |
RNCOS Releases a New Report- Booming Clinical Trials Market in India
|
|
|
RNCOS has recently added a new Market Research Report titled, “Booming Clinical Trials Market in India” to its report gallery. According to our research report, “Booming Clinical Trials Market in India”, India promises to be one of the hottest destinations for conducting global clinical research, owing to a huge patient pool representing both chronic and infectious diseases, easy recruitment of patients, and high cost savings.
India presently occupies a very small pie of the global opportunity. The total number of clinical trials in India stood at 221 in 2007, which equates to less than 2% of the global clinical trials. With all major pharmaceutical/biotech companies and CROs establishing their presence in India, the number of clinical trials in the country is expected to grow several folds in the next five years. The country is projected to conduct nearly 5% of the global clinical trials by 2012. However, to achieve its goal of becoming a global hub of clinical trials, the country has to overcome challenges like unethical trials, delay in trial approval, inappropriate protection of clinical data, and lack of Good Clinical Practice (GCP) certified sites and investigators.
Surging clinical trials market in India will create enormous opportunities for a number of associated industries, including IVD market, education sector and clinical data management.
“Booming Clinical Trials Market in India” gives an extensive and objective analysis on the Indian clinical trials market. It investigates the advantages/disadvantages India has in becoming a global clinical trials hub. The report exhaustively evaluates and compares the key factors that drug companies and CROs look before outsourcing clinical trials to a country. These include parameters such as patient pool, regulatory environment, cost, infrastructure, human resources and past performance in conducting clinical trials. Thus, this analytical study serves as a useful guide for drug manufacturers, CROs, consultants and investors who are planning to enter the Indian clinical trials market.
Our report provides forecasts on
- Size of global clinical research outsourcing market
- Size of Indian clinical research outsourcing market
- Number of clinical trials in India
- Number of patients expected to participate in clinical trials in India
- Clinical trials infrastructure and professionals in India
- Healthcare indicators in India
Key questions answered in the report
- Why are drug manufacturers outsourcing clinical trials?
- Where and how many clinical trials are being outsourced?
- Where dose India stand in the global clinical trials market?
- How big is the clinical trials opportunity in India?
- How much does it cost on hiring personnel for various clinical research processes, rent and utilities in India as compared to other countries?
- How does clinical trials infrastructure and staff in India vary from other countries?
- What are various government regulations/guidelines for conducting clinical trials in India?
- What are the Future trends predicted to shape the clinical trials market in India?
- How is the clinical trials market impacting associated industries?
Key players analyzed in the report
This section provides business overview on prominent players in the Indian clinical research market like Syngene International Ltd, Quintiles Research (India) Private Limited, Lambda Therapeutic Research Ltd, Vimta Labs Limited and Veeda Clinical Research - India.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
|
| 4. |
Get toned Inc. - An Informatics of Healthy Life!!!
|
|
|
December 2008 - “Health is Wealth” is a motto behind this website. Healthy Body is a healthy mind, so one must take care of health and make the best impression among people. The secret of having good abbs is simple and actually not too difficult, but all the same it does take daily routine. Get toned Inc. has been designed for all types of people to make them feel healthy and young. Get toned Inc. gives information about abbs exercise and way for strengthening muscles. There are many exercises which can make us slim and look smart.
Here is the way for reducing our obesity. Get toned Inc. has introduced some of the easy curriculum for abbs workouts. Diet is more important than any other exercises, so one must have keen interest for intake of nutrition based food. Get toned Inc. is making all activities to be at ease and satisfy the customers with more changes in their life.
There are many exercises and workouts which won’t give good result to us, but in this site they have given easy steps for all problems. It is extremely hard to maintain a scheduled diet in this type of culture. There is another guide based on how to get abbs fast in a simple way. Dieting is not a way for making slim body. One must think to decide over easy and comfort for making over hard abbs. These exercises are not similar to cardio exercises or any other sit-ups which are followed in all gym centers. This is the most comfortable and unique guide for making perfect body. To get to know about nutritious diet visit www.howtogetabbs.weebly.com
Nowadays, Junk food is more popular among the youth which increases the calories in a body. There must be limited amount of fat in the body. There are different package programs which is worthy for both men and women to reduce calories in a body. Special tips and workouts for girls’ abbs are given for fat ladies to make their stomach slim. Women are more concerned about their looking postures. Most of them think to have their belly fat and fit in any costume. These exercises show a great change in the shape of abbs. Most of the people use other means of infomercials and exercises for getting hot abbs. But those things are waste of time and money.
This is not similar to slim pills, any slim belts or equipment which is used by many people who don’t know about this site. There are many commercial advertisements which are making fake experience in one’s life. One must take suitable decision for choosing the right means of exercises to make nice abbs. This site assures lots of affordable pleasure and happiness. This guide contains workouts related to girls’ abbs and men abbs.
For more information visit: http://howtogetabbs.weebly.com
|
| 5. |
Protocol Link, Inc
|
|
|
Protocol Link, Inc. is a leading global project management and consulting firm offering comprehensive advisory services to regulated life sciences companies worldwide, including regulatory compliance, validation, and quality assurance services.
At Protocol Link, we strive to offer the best of both quality and efficiency. It’s how we’ve been doing business since 1996. The right way. Knowing that our clients are counting on us. We have maintained our track record of doing our very best to get it right the first time, every time, for 11-plus years. 95% of our business represents repeat engagements with satisfied clients, reflecting our client focus.
We offer an even balance of regulatory expertise and experience. Our consultants are hands-on, analytical, yet strategic. We are driven by providing the best solutions to help our clients meet their business goals. With more than 450 projects completed to date, representing engagements in the US, Australia, Belgium, France, Germany, Italy, Japan, Mexico, The Netherlands, Puerto Rico, Romania, and South Korea, Protocol Link is building a strong worldwide presence. Over the years we have successfully managed projects and advised dozens of firms ranging from Fortune 50 companies to start-up biotechnology firms by offering the following list of specialties:
Services Knowledge
Compliance Planning and Management
Compliance and Readiness Audits
Quality Systems Development
Validation (Plans, Systems, Processes)
CGMP / QA Documentation
Regulatory Affairs & Submission Assistance
Technical Services
Training Programs
Exception Investigations and CAPA
FDA and EU Liaison
Inspectional Observations Preparation Critical Systems / Facilities
Computer Systems
SVP and LVP Processes
Solid Dosage Manufacturing
Packaging and Labeling
Cleaning Processes
Analytical Method Development
Laboratory Controls
Diagnostics and Medical Devices
Contract Manufacturing Oversight
Change Control / Change Management
We invite you to visit our Web site at www.protocollink.com for additional information about our company and the services that we offer. We look forward to serving you.
|
|
|
